Assessment of Erenumab Safety and Efficacy in Patients With Migraine With and Without Aura-Reference-Cited by-同舟云学术

Assessment of Erenumab Safety and Efficacy in Patients With Migraine With and Without Aura

Published:2021-12-20 Issue: Volume: Page:
ISSN:2168-6149
Container-title:JAMA Neurology
language:en
Short-container-title:JAMA Neurol

Author:

Ashina Messoud¹,Goadsby Peter J.²³,Dodick David W.⁴,Tepper Stewart J.⁵,Xue Fei⁶,Zhang Feng⁶,Brennan Francis⁶,Paiva da Silva Lima Gabriel⁶

Affiliation:

1. Danish Headache Center, Department of Neurology, Rigshospitalet Glostrup, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark

2. National Institute for Health Research–Wellcome Trust King’s Clinical Research Facility, King’s College London, London, United Kingdom

3. Department of Neurology, UCLA (University of California, Los Angeles)

4. Department of Neurology, Mayo Clinic, Scottsdale, Arizona

5. Geisel School of Medicine at Dartmouth, Dartmouth College, Hanover, New Hampshire

6. Amgen Inc, Thousand Oaks, California

Publisher

American Medical Association (AMA)

Subject

Neurology (clinical)

Link

https://jamanetwork.com/journals/jamaneurology/articlepdf/2787208/jamaneurology_ashina_2021_oi_210081_1639581495.20466.pdf

Reference21 articles.

1. Migraine: epidemiology and systems of care.;Ashina;Lancet,2021

2. Differences in treatment response between migraine with aura and migraine without aura: lessons from clinical practice and RCTs.;Hansen;J Headache Pain,2019

3. Reduced efficacy of sumatriptan in migraine with aura vs without aura.;Hansen;Neurology,2015

4. Cortical spreading depression and migraine.;Charles;Nat Rev Neurol,2013

5. Calcitonin gene-related peptide: physiology and pathophysiology.;Russell;Physiol Rev,2014

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Patterns of migraine medication use in Norway: A nationwide registry-based observational study;Cephalalgia;2024-08

2. The Effect of Calcitonin Gene-Related Peptide Monoclonal Antibodies on Quality of Life among Migraine Patients: Pilot Study at the Hospital of Lithuanian University of Health Sciences Kaunas Clinics;Acta medica Lituanica;2024-05-22

3. Meningeal lymphatic CGRP signaling governs pain via cerebrospinal fluid efflux and neuroinflammation in migraine models;Journal of Clinical Investigation;2024-05-14

4. Prospective evaluation of aura during anti-calcitonin gene-related peptide monoclonal antibody therapy after 52 weeks of treatment;Confinia Cephalalgica;2024-05-07

5. Effect of anti‐CGRP‐targeted therapy on migraine aura: Results of an observational case series study;CNS Neuroscience & Therapeutics;2024-02